Abstract:1563 Aim: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe but treatable autoimmune disease. The occurrence of anti-NMDAR encephalitis is associated with presence of specific antibodies against NMDAR in central nervous system. So far, several trigger factors were postulated in relation to the development of disease, which are paraneoplastic (especially associated with ovarian teratoma), viral encephalitis-related and cryptogenic. Each type is different in clinical course, treatment strategies and prognosis. This study aims to explore distinct cerebral metabolic abnormalities in patients with anti-NMDAR encephalitis triggered by different factors and its clinical correlates. Methods: Twenty-four patients with anti-NMDAR encephalitis in acute phase from Huashan Hospital, Shanghai were recruited. All patients were diagnosed based on positive antibodies in serum and CSF. We reviewed patients’ imaging features (including brain MRI and 18F-FDG PET) together with clinical information. Each patient was classified into an etiological subgroup. Results: Of the twenty-four patients (17 male, 7 female; median age: 21 years) with anti-NMDAR encephalitis included in this study, thirteen were divided into the cryptogenic group, five patients with ovarian teratomas were divided into the paraneoplastic group and the remaining six were viral encephalitis-related. We found that patients’ onset age, maximum modified Rankin Scale (mRS) had no statistical difference among three groups (all P > 0.05). CSF protein level in viral encephalitis-related group was significantly higher than that in paraneoplastic group and cryptogenic group (P 0.05). For MRI imaging, we observed an overall 50% of all patients presenting with abnormal MRI. Specifically, only three of the thirteen patients in cryptogenic group, three of the five patients in paraneoplastic group, but all patients in viral encephalitis-related were observed with abnormal MRI signals. For 18F-FDG PET imaging, we noted that 100% patients have abnormalities on PET scans, with frontal-temporal-occipital lobes and basal ganglia as the most frequently affected regions. Three subgroups demonstrated distinct characteristics in 18F-FDG PET scans. Both groups of patients with cryptogenic and paraneoplastic anti-NMDAR encephalitis showed bilateral hypermetabolism in the frontal-temporal lobes and basal ganglia, covarying with bilateral hypometabolism in the occipital regions. Notably, the changes of hypermetabolism in the cortical and subcortical regions were usually asymmetric in the patients with cryptogenic encephalitis, but relative symmetric in those associated with tumor. In patient group secondary to viral encephalitis, focal reductions of metabolism in unilateral cerebral cortex were found, mostly affecting the unilateral temporal lobe and part of basal ganglia (the same regions with abnormal signal on MRI), accompanied by slight hypermetabolism in the contralateral temporal regions. Conclusion: This study gave detailed description of distinct brain metabolic abnormalities related to patients with anti-NMDAR encephalitis triggered by different causes. The awareness of such distinct patterns gave an insight to investigate anti-NMDAR encephalitis from a new etiological perspective which might be useful to facilitate early diagnosis, and more importantly, to promote treatment strategies.

Characterization of Neuroinflammation Pattern in Anti-Lgi1 Encephalitis Based on TSPO PET and Symptom Clustering Analysis

Characterization of microglia activation patterns in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis

Microglial Activation Imaging Using 18 F-DPA-714 PET/MRI for Detecting Autoimmune Encephalitis

Microglial Activation Imaging Using 18F-DPA-714 PET/MRI for Detecting Autoimmune Encephalitis.

Activated microglia by 18F-DPA714 PET in a case of anti-LGI1 autoimmune encephalitis

Subcortical Hypermetabolism Associated With Cortical Hypometabolism Is A Common Metabolic Pattern In Patients With Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis

The Different Metabolic Patterns Of Brain 18f-Fdg Pet In Anti-Nmda,Anti-Lgi-1 And Antigabab Encephalitis

Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET

Distinct Cerebral 18F-FDG PET Metabolic Patterns in Anti-N-methyl-d-aspartate Receptor Encephalitis Patients with Different Trigger Factors

Colocalization of Increased Midbrain Signals in Neuroinflammation and Tau PET Imaging Suggests the Diagnosis of Progressive Supranuclear Palsy

The clinical and predictive value of 18F-FDG PET/CT metabolic patterns in a clinical Chinese cohort with autoimmune encephalitis

Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT

Clinical and imaging features of leucine-rich glioma inactivated 1 antibody associated autoimmune encephalitis

Brain 18F-FDG PET Imaging in Patients with Anti-N-methyl-D-aspartate Receptor Encephalitis Triggered by Different Factors: Cerebral Metabolic Abnormalities and Clinical Correlates

18F-DPA714 PET/MRI as a potential imaging tool for detecting possible antibody-negative autoimmune encephalitis: a prospective study

Activated Microglia in the Early Stage of a Rat Model of Parkinson's Disease: Revealed by PET-MRI Imaging by [18F]DPA-714 Targeting TSPO

Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain

Clinical evaluation of neuroinflammation in child-onset focal epilepsy: a translocator protein PET study

Radiosynthesis and evaluation of acetamidobenzoxazolone based radioligand [C-11]N '-MPB for visualization of 18 kDa TSPO in brain

Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease

A Novel Classification Model Based on Cerebral 18F-FDG Uptake Pattern Facilitates the Diagnosis of Acute/Subacute Seropositive Autoimmune Encephalitis